47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,9 | -1 | -1,9 | -89,9 |
EBITDA | -0,5 | 0,6 | 0,2 | -68,8 |
Short time liabilities | 41,9 | 42,8 | 48,4 | 13,2 |
Equity capital | -29,8 | -30,7 | -32,4 | -5,4 |
Operating profit (EBIT) | -0,7 | 0,5 | 0 | -97,3 |
Assets | 12,7 | 13,1 | 17,1 | 29,9 |
Net profit (loss) | -0,9 | -0,9 | -1,7 | -80,1 |
Cash | 0,2 | 0,3 | 0,3 | 18,7 |
Liabilities and provisions for liabilities | 42,5 | 43,9 | 49,5 | 12,7 |
Net income from sale | 65,4 | 75,4 | 84,1 | 11,5 |
Working assets | 9,1 | 9,6 | 13 | 35,2 |
Depreciation | 0,2 | 0,2 | 0,2 | 1 |
% | % | % | p.p. | |
Profitability of capital | 2,9 | 3 | 5,1 | 2,1 |
Equity capital to total assets | -235,5 | -234,3 | -190 | 44,3 |
Gross profit margin | -1,3 | -1,3 | -2,3 | -1 |
EBITDA Margin | -0,7 | 0,9 | 0,2 | -0,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 234 | 207 | 210 | 3 |
Current financial liquidity indicator | 0.21601273119449615 | 0.22244812548160553 | 0.2658679783344269 | 0,1 |
Net dept to EBITDA | -61.97700119018555 | 43.51653289794922 | 159.0880889892578 | 115,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane